14/02/2005
London, UK – 14 February, 2005: ReGen Therapeutics Plc(the “Company”) announces that on 11 February 2005 it received notification from New Opportunities Investment Trust Plc that, following a disposal by it of 1,000,000 ordinary shares of the Company on 10 February 2005, it now retains a holding of ordinary shares of less than the Notifiable Interest level of 3% of the issued share capital of the Company.
For further information, please contact:
Andrew Marshall Tel.
020 7960 6007
Marshall Robinson Roe